AMERICAN SHARED HOSPITAL SERVICES Net Cash Provided by (Used in) Investing Activities, Continuing Operations
AMERICAN SHARED HOSPITAL SERVICES (AMS) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$1.32 million for the 6-month period ending 2017-06-30, per its 10-Q filed 2017-08-10.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2017-08-10
- AMERICAN SHARED HOSPITAL SERVICES net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-06-30 was -$213.00K.
- AMERICAN SHARED HOSPITAL SERVICES net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-03-31 was -$1.11M.
- AMERICAN SHARED HOSPITAL SERVICES net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-12-31 was -$562.00K.
- AMERICAN SHARED HOSPITAL SERVICES net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-09-30 was -$475.00K.
- AMERICAN SHARED HOSPITAL SERVICES net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$1.61M.
- AMERICAN SHARED HOSPITAL SERVICES net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$1.93M.
- AMERICAN SHARED HOSPITAL SERVICES net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$4.45M.
- AMERICAN SHARED HOSPITAL SERVICES net cash provided by (used in) investing activities, continuing operations for fiscal 2013 was -$1.72M.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2017-06-30 | -$213.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | -$1.32M 10-Q · filed 2017-08-10 | -$1.88M derived: sum of 3 quarters · filed 2017-08-10 | -$2.36M derived: sum of 4 quarters · filed 2017-08-10 |
| 2017-03-31 | -$1.11M 10-Q · filed 2017-05-15 | -$1.67M derived: sum of 2 quarters · filed 2017-05-15 | -$2.14M derived: sum of 3 quarters · filed 2017-05-15 | -$2.38M derived: sum of 4 quarters · filed 2017-08-10 |
| 2016-12-31 | -$562.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-27 | -$1.04M derived: sum of 2 quarters · filed 2017-03-27 | -$1.28M derived: sum of 3 quarters · filed 2017-08-10 | -$1.61M 10-K · filed 2017-03-27 |
| 2016-09-30 | -$475.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | -$717.00K derived: sum of 2 quarters · filed 2017-08-10 | -$1.05M 10-Q · filed 2016-11-10 | -$1.45M derived: sum of 4 quarters · filed 2017-08-10 |
| 2016-06-30 | -$242.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | -$575.00K 10-Q · filed 2017-08-10 | -$974.00K derived: sum of 3 quarters · filed 2017-08-10 | -$1.15M derived: sum of 4 quarters · filed 2017-08-10 |
| 2016-03-31 | -$333.00K 10-Q · filed 2017-05-15 | -$732.00K derived: sum of 2 quarters · filed 2017-05-15 | -$910.00K derived: sum of 3 quarters · filed 2017-05-15 | -$2.07M derived: sum of 4 quarters · filed 2017-05-15 |
| 2015-12-31 | -$399.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-27 | -$577.00K derived: sum of 2 quarters · filed 2017-03-27 | -$1.74M derived: sum of 3 quarters · filed 2017-03-27 | -$1.93M 10-K · filed 2017-03-27 |
| 2015-09-30 | -$178.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | -$1.34M derived: sum of 2 quarters · filed 2016-11-10 | -$1.53M 10-Q · filed 2016-11-10 | -$6.41M derived: sum of 4 quarters · filed 2017-03-27 |
| 2015-06-30 | -$1.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | -$1.35M 10-Q · filed 2016-08-11 | -$6.23M derived: sum of 3 quarters · filed 2017-03-27 | -$6.27M derived: sum of 4 quarters · filed 2017-03-27 |
| 2015-03-31 | -$188.00K 10-Q · filed 2016-05-12 | -$5.07M derived: sum of 2 quarters · filed 2017-03-27 | -$5.11M derived: sum of 3 quarters · filed 2017-03-27 | -$4.49M derived: sum of 4 quarters · filed 2017-03-27 |
| 2014-12-31 | -$4.88M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-27 | -$4.92M derived: sum of 2 quarters · filed 2017-03-27 | -$4.30M derived: sum of 3 quarters · filed 2017-03-27 | -$4.45M 10-K · filed 2017-03-27 |
| 2014-09-30 | -$46.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $573.00K derived: sum of 2 quarters · filed 2015-11-12 | $426.00K 10-Q · filed 2015-11-12 | $2.01M derived: sum of 4 quarters · filed 2016-03-30 |
| 2014-06-30 | $619.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-19 | $472.00K 10-Q · filed 2015-08-19 | $2.06M derived: sum of 3 quarters · filed 2016-03-30 | -$685.00K derived: sum of 4 quarters · filed 2016-03-30 |
| 2014-03-31 | -$147.00K 10-Q · filed 2015-05-14 | $1.44M derived: sum of 2 quarters · filed 2016-03-30 | -$1.30M derived: sum of 3 quarters · filed 2016-03-30 | -$1.75M derived: sum of 4 quarters · filed 2016-03-30 |
| 2013-12-31 | $1.58M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | -$1.16M derived: sum of 2 quarters · filed 2016-03-30 | -$1.60M derived: sum of 3 quarters · filed 2016-03-30 | -$1.72M 10-K · filed 2016-03-30 |
| 2013-09-30 | -$2.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | -$3.19M derived: sum of 2 quarters · filed 2014-11-14 | -$3.31M 10-Q · filed 2014-11-14 | |
| 2013-06-30 | -$448.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-15 | -$567.00K 10-Q · filed 2014-08-15 | ||
| 2013-03-31 | -$119.00K 10-Q · filed 2014-05-15 | |||
| 2012-12-31 | -$6.67M 10-K · filed 2015-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |